Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con
✦ LIBER ✦
Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC)
✍ Scribed by Joseph Brenner; Gordon B. Magill; Paul Wissel; Peter P. Sordillo
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 313 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Treatment of advanced soft tissue sarcom
✍
Bari?ta, ?brah??m; Tekuzman, G�lten; Yal�in, ?uay??b; G�ll�, ?brah??m; G�ler, N?
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 101 KB
👁 2 views
Phase II trial of cisplatin (CPDD) in pr
✍
Joseph Brenner; Gordon B. Magill; Peter P. Sordillo; Edgar W. Cheng; Allan Yagod
📂
Article
📅
1982
🏛
John Wiley and Sons
🌐
English
⚖ 249 KB
👁 2 views
Thirty-six previously treated adult patients with advanced soft tissue sarcomas received CPDD 120 mg/m2 with mannitol diuresis. There were only two (6%) partial responses and five (15%) minor responses in 34 evaluable patients. Toxicity included nausea and vomiting, myelosuppression, mild ototoxicit